深科技(000021.SZ):控股股東非公開發行面值不超20億元可交換債獲深交所無異議函
格隆匯11月15日丨深科技(000021.SZ)公佈,公司於今日收到公司控股股東中國電子信息產業集團有限公司(“中國電子”)的通知,中國電子已獲得深圳證券交易所(“深交所”)出具的《關於中國電子信息產業集團有限公司2019年非公開發行可交換公司債券符合深交所轉讓條件的無異議函》(深證函〔2019〕619號),中國電子擬以其持有的部分公司A股股票為標的,申請確認發行面值不超過20億元人民幣的中國電子2019年非公開發行可交換公司債券符合深交所的轉讓條件,深交所無異議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.